Ghana’s National Vaccine Institute (NVI) has joined the Global Clinical Trials Forum (GCTF). The World Health Organisation (WHO) manages this global network. It supports stronger clinical trial systems worldwide.
This admission places Ghana among countries working closely with the WHO. It also partners with international health bodies. The goal is to improve research standards and strengthen collaboration. The forum also promotes ethical clinical trials.
The NVI’s membership aligns with Ghana's broader push for self-sufficiency in public health. Ghana seeks to reduce reliance on imported vaccines. This move follows ongoing efforts to bolster domestic healthcare infrastructure. It also builds on past initiatives to enhance research capabilities within the country.
Professor Samuel Essien-Baidoo confirmed the development. He is the Acting Director of Research and Development at the NVI. He stated Ghana would receive valuable technical support. The membership also provides collaboration opportunities. There are no financial obligations for the institute.
Ghana applied to join the forum after a recommendation from the WHO. This followed a successful stakeholder workshop. The Global Clinical Trials Forum was created under the WHO. Member states at the World Health Assembly agreed that clinical trial infrastructure needed better support.
The forum is a WHO-led platform. It brings together governments, research institutions, and regulators. Healthcare providers, patient groups, and industry associations also participate. They share knowledge, promote best practices, and strengthen clinical trial systems.
Membership gives the NVI access to a global network of health authorities and research institutions. It also provides technical expertise. This allows Ghana to collaborate on research and improve its clinical trial capacity. The NVI will join discussions and working groups. It will also contribute expertise on vaccines and public health. This helps align national policies with WHO standards. It also supports knowledge sharing at national and regional levels.
Ghana intends to play a leadership role in policy and technical discussions. The discussions will focus on priorities for lower and middle-income countries. The forum aims to make clinical trial approvals more efficient. It also helps countries build lasting research capacity. Members receive quarterly updates and participate in bi-annual reviews. These reviews assess progress and identify improvements.
The NVI's admission supports its goal of local vaccine production in Ghana. Dr. Sodzi Sodzi-Tettey leads the institute. It aims for its first locally made vaccine by 2027. Full local vaccine production is targeted for 2030. This membership offers crucial technical tools and training resources. It also provides international partnerships. These will improve the quality and safety of clinical trials in Ghana.